We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.
Deadlines
 

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34)
Deadline: January 12, 2018 05:00 PM



Save this event to your calendar.  Download to Outlook Download to iCal

RFA-HL-18-008: Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34)

The purpose of this FOA is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. The FOA will support the development of feasible and well-designed clinical trials utilizing consultative services provided by the Innovative Clinical Trials Resource (ICTR) (N01).

Read the full RFA here.


Return to Deadline Listings